Home
About
Overview
Sharing Data
ORCID
Help
History (4)
IL-1, quo vadis?
Prevalence of hepatitis C virus antibody in a cohort of hemophilia patients.
Prolonged survival of mouse skin allografts in recipients treated with donor splenocytes and antibody to CD40 ligand.
Survival advantage of black patients with kidney disease after acute myocardial infarction.
See All 4 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
IL-1, quo vadis?
Grebe A, Latz E. IL-1, quo vadis? Atherosclerosis. 2012 Jun; 222(2):324-5.
View in:
PubMed
subject areas
Animals
Aorta
Aortic Diseases
Apolipoproteins E
Atherosclerosis
Humans
Inflammation Mediators
Interleukin-1
Male
Receptors, Interleukin-1 Type I
authors with profiles
Eicke Latz MD